Zydus Recalls Bromocriptine Mesylate Capsules Due to Stability Test Failures
Zydus Pharmaceuticals is recalling 14,808 bottles of Bromocriptine Mesylate 5 mg capsules because stability samples failed impurity tests.
- Product
- BROMOCRIPTINE MESYLATE — BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)
- Category
- Drug
- Distribution
- Distributed nationwide